EcoDrugPlus

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSSTUG00000034013
Gene Symbol: PPARG
3 Cross references
389 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSSTUG00000008239
Gene Symbol: LOC115192671
3 Cross references
390 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSSTUG00000029576
Gene Symbol: LOC115196970
3 Cross references
390 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Delta-Like

Ensembl ID : ENSSTUG00000048144
Gene Symbol: LOC115169027
3 Cross references
389 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Gamma-Like

Ensembl ID : ENSSTUG00000019571
Gene Symbol: LOC115166142
2 Cross references
333 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Gamma-Like

Ensembl ID : ENSSTUG00000004031
Gene Symbol: LOC115168395
2 Cross references
333 Possible Orthologues:

Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase 1-Like

Ensembl ID : ENSSTUG00000007849
Gene Symbol: LOC115151452
2 Cross references
208 Possible Orthologues:

Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase 1-Like

Ensembl ID : ENSSTUG00000022440
Gene Symbol: LOC115158897
2 Cross references
207 Possible Orthologues:

Phosphatidylinositol 3-Kinase Regulatory Subunit Alpha

Ensembl ID : ENSSTUG00000050064
Gene Symbol: LOC115159695
3 Cross references
196 Possible Orthologues:

Phosphatidylinositol 3-Kinase Regulatory Subunit Alpha-Like

Ensembl ID : ENSSTUG00000032112
Gene Symbol: LOC115167650
3 Cross references
53 Possible Orthologues:

Phosphatidylinositol 3-Kinase Regulatory Subunit Alpha-Like

Ensembl ID : ENSSTUG00000013798
Gene Symbol: LOC115203963
3 Cross references
196 Possible Orthologues:

Phosphatidylinositol 3-Kinase Regulatory Subunit Gamma-Like

Ensembl ID : ENSSTUG00000045156
Gene Symbol: LOC115156743
3 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).